Dietitian home visits may boost quality of life in head and neck cancer patients
NCT ID NCT02510859
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether having a dietitian visit patients at home during radiotherapy could improve their quality of life. 117 adults with head and neck cancer took part. The goal was to see if personalized nutrition advice helps patients cope better with treatment side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- home dietary consultation
- What this could lead to
- If it works, this could show that simple nutritional support at home improves quality of life for head and neck cancer patients during radiotherapy.
- What could go wrong
- This is a completed trial, but the primary outcome is a subjective quality-of-life score, which may not show a clear benefit. The intervention is supportive care, not a treatment for the cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service ORL et de chirurgie cervico- faciale
Caen CHU, 14000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new drug boost the power of chemoradiation against head and neck cancer?
- Experimental antibody combo aims to boost immune attack on head and neck tumors
- Scientists hunt for blood markers to unmask hidden aggressive tumors
- Liver damage study in head and neck cancer abandoned after just 2 patients
- New antibody drug takes aim at Hard-to-Treat cancers